Skip to main content
Go back to Resources
The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation.
Authors:
Secondary:
Volume:
Pagination:
PMID:
DOI:
Abstract:
Go back to Resources
Go back to Resources
Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Spinal Cord Injury (SCI) Common Data Element Recommendations
Authors:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
NINDS Cerebral Palsy Common Data Elements: Updates; Relationship to the International Classification of Functioning, Disability, and Health (ICF); Applications for International Research and Clinical Utility
Authors:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Friedreich’s ataxia Common Data Element Review: Updates to the National Institute of Neurological Disorders and Stroke Friedreich’s ataxia (FA) Common Data Element Recommendations: 2018 FA Working Group Review
Authors:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
The National Institute of Neurological Disorders and Stroke (NINDS) Updates to the Spinal Cord Injury (SCI) Common Data Element Recommendations
Authors:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials.
Authors:
Secondary:
Volume:
Pagination:
PMID:
URL:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.
Authors:
Secondary:
PMID:
URL:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
URL:
DOI:
Keywords:
Abstract:
Go back to Resources